A Phase 2a Single-Arm, Open-Label, Multicenter Exploratory Study to Assess the Effects of Sotatercept (ACE-011) for the Treatment of Pulmonary Arterial Hypertension
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 29 Dec 2018
At a glance
- Drugs Sotatercept (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Acronyms SPECTRA
- 15 Nov 2018 New trial record
- 08 Nov 2018 Status changed from planning to not yet recruiting.
- 30 Oct 2018 According to an Acceleron Pharma media release, the company expects to start this study in Q1 2019.